Table 3 The statistic analyses of 29 pelvic GCT patients basing on the treatment group
From: Surgical treatment for pelvic giant cell tumor: a multi-center study
Categories | S (IL) | S (W) | Total | p |
|---|---|---|---|---|
Number, n (%) | 8 (27.6) | 21 (72.4) | 29 (100) | – |
Age, year, means (SD) | 34.8 (9.0) | 41.0 (9.0) | 39.2 (9.3) | 0.732 |
Age group, n (%) | 0.190 | |||
<20 | 1 (12.5) | 0 (0) | 1 (3.4) | |
20~29 | 0 (0) | 2 (9.5) | 2 (6.9) | |
30~39 | 5 (62.5) | 7 (33.3) | 12 (41.4) | |
40~49 | 2 (25.0) | 7 (33.3) | 9 (31.0) | |
≥50 | 0 (0) | 5 (23.8) | 5 (17.2) | |
Sex, n (%) | 0.035 | |||
Male | 1 (7.1) | 13 (92.9) | 14 (48.3) | |
Female | 7 (46.7) | 8 (53.3) | 15 (51.7) | |
Location,a n (%) | 0.691 | |||
I | 2 (25.0) | 8 (38.1) | 10 (34.5) | |
II | 4 (50.0) | 7 (33.3) | 11 (52.4) | |
III | 2 (25.0) | 6 (28.6) | 8 (27.6) | |
Follow-up, months, means (SD) | 85.1 (52.1) | 49.3 (35.4) | 59.0 (42.7) | 0.056 |
Recurrence, n (%) | 0.814 | |||
Exist | 1 (12.5) | 2 (9.5) | 3 (10.3) | |
None | 7 (87.5) | 19 (90.5) | 26 (89.7) | |
Complication, n (%) | 0.635 | |||
Exist | 1 (12.5) | 6 (28.6) | 7 (24.1) | |
None | 7 (87.5) | 15 (71.4) | 22 (75.9) | |
MSTS, means (SD) | 25.4 (3.6) | 21.9 (3.5) | 22.8 (3.8) | 0.024 |